Finally, selective inhibition of IDO with the small molecule INCB024360 was found to improve T-cell proliferation and promote IFNγ production, thereby inhibiting tumor growth in a lymphocyte-dependent manner (109). The gene discussed is IDO1; the disease is neoplasm.